drugIndia
Cart
Already at best price
Glizid-MV Tablet SR

Glizid-MV Tablet SR

Voglibose (0.2mg) + Gliclazide (80mg) + Metformin (500mg)

Panacea Biotec Pharma Ltd
ANTI-INFECTION
142.50178.1220% OFF
In Stock
1
Safe & Secure
Easy Returns
24/7 Support
Delivery
142.5020% OFF
178.12

About This Medicine

Product description & overview

Glizid-MV Tablet SR: A Powerful Combination for Blood Sugar Control

Glizid-MV Tablet SR combines the effectiveness of Voglibose, Metformin, and Gliclazide in a single, convenient dose. This unique formulation provides comprehensive blood sugar management, catering to individual patient needs.

Voglibose (0.2mg) enhances insulin sensitivity, improving glucose uptake by cells.
Metformin (500mg) acts as a powerful antidiabetic agent, reducing hepatic glucose production and delaying glucose absorption.
Gliclazide (80mg) promotes insulin secretion, further optimizing blood sugar regulation.

Benefits of Glizid-MV:

* Lowered blood glucose levels: Improves overall glycemic control across various types of diabetes.
* Reduced risk of complications: Aids in preventing diabetic-related complications by effectively managing blood sugar fluctuations.
* Convenient single-dose formulation: Provides ease of administration for optimal compliance and treatment effectiveness.

This medication is prescribed and should be taken under the guidance of a healthcare professional. Please consult with your doctor before taking this medication, especially if you have pre-existing conditions or are pregnant/breastfeeding.

Active composition

Voglibose 0.2 mg

+2 more active ingredients

About Voglibose

Voglibose is an alpha-glucosidase inhibitor used to manage type 2 diabetes by preventing carbohydrate absorption in the intestines. It helps control post-meal blood sugar spikes and is often used in conjunction with diet and exercise. In summary, it aids in effective diabetes management.

How It Works

Voglibose inhibits intestinal alpha-glucosidases, delaying carbohydrate digestion and absorption, thus lowering postprandial glucose levels.

Medicine Strength
0.2 mg

All Active Ingredients

Voglibose0.2 mg
Gliclazide80 mg
Metformin500 mg

Gliclazide

Gliclazide stimulates insulin secretion from pancreatic beta cells and enhances insulin sensitivity in peripheral tissues.

Metformin

Metformin reduces hepatic glucose production and enhances peripheral insulin sensitivity, lowering blood glucose levels.

Dosage & How to Use

Dosage information not available. Please consult your doctor or pharmacist.

Safety Advice

Important precautions

Side Effect Occurrence

Based on clinical trials and patient reports.

Overall Tolerance

Most patients tolerate well

Only 2.3% reported effects

Common Side Effects

Headache8%
Nausea5%
Dizziness3%
Fatigue2%
Rash1%
Higher
Lower

Safety Advice

Alcohol

Glizid-MV Tablet SR may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.

High Risk

Pregnancy

Glizid-MV Tablet SR should be used with caution during breastfeeding. Breastfeeding should be held until the treatment of the mother is completed and the drug is eliminated from her body.

Medical Advice

Driving

Glizid-MV Tablet SR should be used with caution in patients with kidney disease. Dose adjustment of Glizid-MV Tablet SR may be needed. Please consult your doctor. Use of Glizid-MV Tablet SR is, however, not recommended in patients with severe kidney disease. Regular monitoring of kidney function test is advisable while you are taking this medicine.

Exercise Caution

Breastfeeding

Your ability to drive may be affected if your blood sugar is too low or too high. Do not drive if these symptoms occur.

Consult Doctor

Kidney

Glizid-MV Tablet SR should be used with caution in patients with liver disease. Dose adjustment of Glizid-MV Tablet SR may be needed. Please consult your doctor. Glizid-MV Tablet SR is generally started with low dose in patients with mild to moderate liver disease and its use is not recommended in patients with severe liver disease.

Regular Checkup

Customer Reviews

0 reviews for Glizid-MV Tablet SR

Products matching your search